Cleland, J. G.F. (2022) Aspirin for primary and secondary prevention of cardiovascular disease: time to stop? Thrombosis and Haemostasis, 122(3), pp. 311-314. (doi: 10.1055/s-0041-1740639) (PMID:35052007)
Text
265451.pdf - Accepted Version 332kB |
Abstract
No abstract available.
Item Type: | Articles (Editorial) |
---|---|
Additional Information: | Invited Editorial Focus. |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Cleland, Professor John |
Authors: | Cleland, J. G.F. |
Subjects: | R Medicine > R Medicine (General) |
College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson Centre |
Journal Name: | Thrombosis and Haemostasis |
Publisher: | Georg Thieme Verlag |
ISSN: | 0340-6245 |
ISSN (Online): | 2567-689X |
Published Online: | 20 January 2022 |
Copyright Holders: | Copyright © 2022 Thieme |
First Published: | First published in Thrombosis and Haemostasis 122(3): 311-314 |
Publisher Policy: | Reproduced in accordance with the publisher copyright policy |
University Staff: Request a correction | Enlighten Editors: Update this record